Skip to main content

stock

ORMP · ORAMED PHARMACEUTICALS INC.

What ORAMED PHARMACEUTICALS INC. reports to the SEC, read from its filings.

Open in the app

Price

The live ORMP price and today's change.

Sign in to see this

Chart

Thirty days of daily bars, with signal levels drawn on them.

Sign in to see this

Signals

The latest signal group Nakagai's scanner recorded on ORMP.

Sign in to see this

Options positioning

Gamma exposure levels from the options market.

Sign in to see this

Technicals

Trend, momentum and volatility gauges per timeframe.

Sign in to see this

What it is

Industry
Pharmaceutical Preparations (SIC 2834)
Filer (SEC EDGAR)
EDGAR filing index
Shares outstanding
41,597,354 as of 2026-08-10 (XBRL frame CY2026Q2I)

Key stats

Valuation

P/E
Locked
P/S
Locked
P/B
Locked
Enterprise value
Locked
EV/EBIT
Locked
FCF yield
Locked

Margins

Gross
—
Operating
—
Net
—

Returns

ROE
34.9%
ROA
30.0%

Health

Current ratio
5.0x
Debt/equity
—

Deep value

NCAV
—
NCAV per share
—
Price/NCAV
Locked
NNWC
—
NNWC per share
—
Price/NNWC
Locked

Valuation and the price multiples are built on the live price. Trailing twelve months to 2026-06-30; balance sheet at 2026-06-30.

Sign in to see this

Debt is long-term debt and its current portion. Commercial paper and short-term borrowings are not counted.

Results

Period endRevenueGross profitOperating incomeNet incomeFiling
2026-06-30——-$2.77M$78.16M
10-Q filed 2026-08-10
2026-03-31——-$3.66M$38.31M
10-Q filed 2026-05-19
2025-12-31——-$5.67M-$53.97M
DEF 14A filed 2026-08-03
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2025-09-30——-$2.43M$48.40M
10-Q filed 2025-11-13
2025-06-30——-$2.49M$13.29M
10-Q filed 2026-08-10
2025-03-31$2.00M$13,000-$4.50M-$7.64M
10-Q filed 2026-05-19
2024-12-31——-$3.60M$8.86M
DEF 14A filed 2026-08-03
Derived: the full year minus the first three quarters, not a figure this filer reported as a quarter.
Assembled from more than one filing; the filing above is only the newest of them.
2024-09-30——-$3.09M-$19.62M
10-Q filed 2025-11-13
Assets
$369.64M
Equity
$317.47M

Balance as of 2026-06-30.

Ten years

Fiscal year endRevenueOperating incomeNet incomeFree cash flow
2025-12-31$2.00M-$15.09M$75,324-$9.15M
2024-12-31—-$12.78M-$15,920-$8.43M
2023-12-31$1.34M-$15.77M$5,088-$10.55M
2022-12-31$2.70M-$40.60M-$36.56M-$28.41M
2021-08-31$2.70M-$24.22M-$22.99M-$21.56M
2020-08-31$2.71M-$11.76M-$11.51M-$12.52M
2019-08-31$2.70M-$14.63M-$14.36M-$12.96M
2018-08-31$2.45M-$13.53M-$12.73M-$14.66M
2017-08-31$2.46M-$10.77M-$10.48M-$5.84M
2016-08-31$641,000-$10.01M-$10.96M$4.65M

Company filings

events

  • Shareholder vote results

    Shareholder vote results
    Sep 178-K
  • Bylaws or fiscal year change, Other event

    Bylaws or fiscal year changeOther event
    Jun 308-K
  • Material agreement, Acquisition or sale completed

    Material agreementAcquisition or sale completed
    Mar 318-K
  • Material agreement

    Material agreement
    Feb 208-K
  • Material agreement, Other event

    Material agreementOther event
    Jan 148-K
  • Other event

    Other event
    Jan 78-K

5% owners ()

Insiders, politicians and funds

Insider trades, last 90 days

  • Gabay Avraham

    Chief Financial Officer

    Sale$90,200

    Oct 2, 5:19 PM ET

  • Hexter Joshua

    COO & CBO

    Sale$135,330

    Oct 2, 5:19 PM ET

All insider trades for ORMP

Politician trades, last 90 days

No politician trades filed in the last 90 days.

Funds

None of the tracked funds held this at their last 13F.

News

Stories that named ORMP, and the market events around them.

Sign in to see this

Board

Recent signals

Signals open up here once a member has posted about ORMP.

Signals are informational.

Posts · 0

No posts yet.

Be the first to say something about ORMP.

nakagai

Signals on ORMP come from a rule, not a model.

Nakagai’s scanner records a signal the moment a strategy’s rule matches on the bars. Members read those signals on their own desk, where an agent journals the tape and briefs them in plain English.

Members post on the ORMP board

This page is not financial advice. Trade at your own judgment and risk. Read the terms that govern posting here.

ORAMED PHARMACEUTICALS INC. (ORMP): SEC filings, financials and insider trades · Nakagai